Advocacy

The Cord Blood Association has five priorities, none more important than advocacy. The association is representing the interests of the cord blood community in:

U.S. Capitol Building | Architect of the Capitol
  • Legislation
  • Regulation
  • Media relations
  • Health professional education
  • Parent education

For most of its history, since the first cord blood transplant in the late 1980s and the founding of the first cord blood bank in the early 1990s, there has been no industry-wide organization or voice for the cord blood community. Advocacy has been left to individual banks, registries, physician organizations and patient groups – each with its own perspective and sometimes distracting interests.

That’s worked to a degree. But the need for an organization precisely focused on cord blood was recognized overwhelmingly by industry representatives gathered for a global conference in 2014. The CBA, its structure, governance and programs, was created to fulfill that need.

The CBA is the new force for the cord blood community in government affairs and health professional and public education.

Legislative Reports

The CBA Legislative Reports provide comprehensive updates on congressional activities pertinent to the cord blood industry, aimed at advancing medicine and advocating for the field. Stay informed with our quarterly updates to understand the latest developments shaping the regulatory landscape for cord blood banking.

Legislative updates and insights provided by Sidley Austin, the dedicated lobbyist for CBA.

Recent News

Family Cord Blood Banking Act Bill

CBA Letter to the Editor of the New York Times, In Response to July 15 Article on Cord Blood Banking (Pending Review by the NYT)

CBA Works with Congress to Allow Blood Stem Cell Products in Cabins of Commercial Aircrafts

Circular of Information for the Use of Cellular Therapy Products

FDA Removes Zika Virus from the List of RCDADs for HCT/Ps

FDA Finalizes Rule on Laboratory Developed Tests

Evaluating Approaches to Diagnostic Test Regulation and the Impact of the FDA's Proposed Rule

National Cord Blood Inventory Re-Authorized through FY2025

E.U. Begins Blood, Tissue and Cell Regulations Update

COVID-19: Cord Blood Inventories Safe and Readily Available

Model Criteria Adopted for Banking Laws and Regulations

Top Ten Essentials for Cord Blood Banking

Comparison of Cord Blood Banking Standards and Voluntary Accreditations

CBA Seeks Harmony for Rules and Regulations

Statement on Delayed Umbilical Cord Clamping

Guidelines for Zika Virus Screening

Vigilance Encouraged for Ebola Virus Safety

U.S. Congress Approves Stem Cell Act Reauthorization